UK Dry Powdered Inhaler Market Size, Share, Forecast, Analysis, Industry Report

Posted by mansi on February 18th, 2020

UK dry powdered inhaler market is anticipated to grow at a substantial rate of around 1.2% during the forecast period. The dry-powder inhaler (DPI) is used to deliver medication to the lungs in the dry powder form. It finds a significant role to treat respiratory diseases including asthma, bronchitis, emphysema, and COPD. As the prevalence of asthma and other respiratory diseases increases across UK, the demand for dry powdered inhalers is also expected to increase for treatment purposes. As per the International Monetary Fund GDP of the country was .9 trillion in 2017. UK comprises England, Scotland, Wales and Northern Ireland. The total population of the country in 2017 was 65 million, out of which about 18% are of the geriatric population. Mortalities related to asthma and COPD are high in UK and due to these a significant investment by the government and people can be forecast in the near future.

Request a Free Sample of our Report UK Dry Powdered Inhaler Market

UK dry powdered inhaler market is segmented based on type, application, and end-user. Based on the type, preventive, reliever, and long-acting bronchodilators dry powdered inhalers are analyzed. The preventive dry powdered inhaler segment led the global dry powdered inhaler market in 2018. Preventive inhalers are most widely used in the treatment of asthma in children and adults. These inhalers do not entail side effects for long-term use, and exceptionally decreases the possibility of an asthma exacerbation. The preventive inhalers further reduce the airways swelling and hence, are recommended for regular use by the physician. Some of the preventive inhalers available in the market include Budesonide and Fluticasone. Moreover, based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.

A full Report of UK Dry Powdered Inhaler Market is Available at:

UK Dry Powdered Inhaler Market Segmentation

By Type

  • Preventive Inhaler
  • Reliever Inhaler
  • Long Acting Bronchodilators Dry Powdered Inhaler 

By Application

  • Asthma 
  • Chronic Obstructive Pulmonary Disease (COPD)

By End-User

  • Homecare
  • Hospitals and Clinics

Company Profiles

  • 3M Co.
  • Acorda Therapeutics, Inc.
  • Adamis Pharmaceuticals Corp.
  • Adherium Ltd.
  • AstraZeneca PLC
  • Bespak
  • Boehringer Ingelheim International GmbH
  • Chiesi Farmaceutici S.P.A.
  • GF Health
  • GlaxoSmithKline PLC
  • H&T Presspart Manufacturing Ltd.
  • Koninklijke Philips N.V.
  • Novartis AG
  • Omron Healthcare Inc.
  • ResMed Corp.
  • Pulmatrix Inc.
  • Savara, Inc.
  • Teicos Pharma Ltd.
  • Teva Pharmaceuticals Industries Ltd.
  • Vitalograph Ltd.

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari


Contact no: +1 646-755-7667, +91 7803040404

Like it? Share it!


About the Author

Joined: January 22nd, 2020
Articles Posted: 169

More by this author